T cell transfer after allo-HSCT in AML

被引：0
|
作者：
Diana Romero
机构：
[1] Nature Reviews Clinical Oncology,
来源：
Nature Reviews Clinical Oncology | 2019年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：528 / 528
相关论文
共 50 条
  • [1] T cell transfer after allo-HSCT in AML
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) : 528 - 528
  • [2] Sorafenib prevents AML relapse after allo-HSCT
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (10) : 591 - 591
  • [3] Sorafenib prevents AML relapse after allo-HSCT
    Diana Romero
    Nature Reviews Clinical Oncology, 2020, 17 : 591 - 591
  • [4] MOLECULAR MARKERS AND ALLO-HSCT FOR AML: AN UPDATE
    Schmid, C.
    Esteve, J.
    Labopin, M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S90 - S90
  • [5] T cell immune reconstitution in leukemia patients with cGVHD after allo-HSCT
    Wu, X.
    Li, Y.
    Zhu, K.
    Chen, S.
    Yang, L.
    Du, X.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 111 - 111
  • [6] Molecular markers and allo-HSCT for AML: the latest developments
    Esteve, J.
    Labopin, M.
    Brunet, S.
    Pigneux, A.
    Brands-Nijenhuis, M.
    Schouten, H.
    Polge, E.
    Gorin, N. -C.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S5 - S5
  • [7] Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT
    Kato, Koji
    Miyamoto, Toshihiro
    Yonemoto, Koji
    Uchida, Naoyuki
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Takahashi, Satoshi
    Ohashi, Kazuteru
    Eto, Tetsuya
    Nagamura-Inoue, Tokiko
    Sakamaki, Hisashi
    Morishima, Yasuo
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Akashi, Koichi
    BLOOD, 2014, 124 (21)
  • [8] Extramedullary relapse of the AML following allo-HSCT: a case report
    Ciftciler, R.
    Aladag, E.
    Okay, M.
    Goker, H.
    LEUKEMIA RESEARCH, 2018, 73 : S42 - S42
  • [9] Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT
    Zhang, Tongtong
    Bao, Xiebing
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Fu, Chengcheng
    Sun, Aining
    Ruan, Changgeng
    Wu, Depei
    Chen, Suning
    Xu, Yang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Impact of cell dose in BM and PBSC on outcome after allo-HSCT
    Remberger, M.
    Ringden, O.
    Uhlin, M.
    Mattsson, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S108 - S108
12345